Philippines

Resilience System

Main menu


You are here

Home

Treatments

U.S. FDA cleares the first home flu and Covid test — but its maker just declared bankruptcy

Mon, 2023-02-27 23:33 — mike kraft
The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy The FDA's authorization of the first at-home test that can detect flu and Covid-19 came just days after the test's maker, Lucira, filed for bankruptcy. Brittany Trang STAT
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Pandemics
Public Health
Research
Science
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

Fri, 2023-02-24 00:54 — mike kraft
CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted in favor of use of Bavarian Nordic's Jynneos vaccine for all adults at risk of mpox during an outbreak. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
Mpox
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

COVID-19 vaccination may lower risks of heart attack, stroke if infected--study

Thu, 2023-02-23 23:50 — mike kraft
COVID-19 vaccination may lower risks of heart attack, stroke if infected - UPI.com Researchers linked COVID-19 vaccination with fewer heart attacks, strokes and other cardiovascular issues among people who later got COVID-19. UPI

COVID-19 shot may protect a person from more than the virus alone, new research suggests.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

COVID-19 Rebound Can Happen Even Without Paxlovid

Thu, 2023-02-23 07:14 — mike kraft
COVID-19 Rebound Can Happen Even Without Paxlovid New research provides more data for people weighing the risks and benefits of taking the antiviral drug Paxlovid for COVID-19. YahooNews

...

Various studies and anecdotal data have found vastly different rates of rebound among both Paxlovid users and untreated people.arious studies and anecdotal data have found vastly different rates of rebound among both Paxlovid users and untreated people. ...

Country / Region Tags: 
Global
United States
General Topic Tags: 
Symptoms
Treatments
Disease
Health
Medical Testing
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

COVID pills fail to prevent infection among household members

Wed, 2023-02-22 22:42 — mike kraft
Merck's COVID pill fails to prevent infection among household members Merck & Co Inc said on Tuesday its COVID-19 pill was not effective at cutting the risk of coronavirus infections in people living with someone infected with the virus. Reuters Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease
Disease Prevention
Health
Mutations
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Corrected entry: Higher ivermectin dose, longer duration still ineffective for COVID, new trial

Wed, 2023-02-22 08:31 — mike kraft
Higher ivermectin dose, longer duration still futile for COVID, trial finds CIDRAP

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Pandemics
Politics
Public Health
Research
Science
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Ivermectin: Higher dose, longer duration still ineffective for COVID, new trial finds

Wed, 2023-02-22 08:09 — mike kraft
Higher ivermectin dose, longer duration still futile for COVID, trial finds CIDRAP

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Public Attitudes
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

Vaccinations: African leaders urge greater immunization efforts amid calls for developing new vaccines

Tue, 2023-02-21 06:43 — mike kraft
African leaders call for urgent action to revitalize routine immunization | WHO | Regional Office for Africa African heads of state today agreed on key measures to revamp routine immunization across the continent following massive disruptions by the COVID-19 pandemic that stymied childhood vaccination programmes and heightened outbreaks of vaccine-preventable diseases. WHO | Regional Office for Africa
Country / Region Tags: 
Global
United Nations
General Topic Tags: 
Treatments
Disease
Disease Prevention
Health
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

COVID increases risk for cardiac complications—suggestions for protection

Mon, 2023-02-20 23:05 — mike kraft
COVID increases your risk for cardiac complications—immediately and into the future, experts say. Here’s how you can protect your heart Long COVID isn’t the only opportunity for the virus to wreak havoc later on. YahooFinance

...

With COVID here to stay, what can the average person do to protect their heart?

Keeping heart-healthy pre-COVID looks largely the same during COVID, Dr. Michelle Albert, president of the American Heart Association, tells Fortune.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Disease Prevention
Health
Public Health
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis

Black, Hispanic people may be more likely to have undiagnosed, untreated long COVID--study

Mon, 2023-02-20 22:43 — mike kraft
Black, Hispanic people may be more likely to have long COVID but not be diagnosed Also, the single available medical code for long COVID may not capture the wide variation in symptoms and severity. CIDRAP
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Contagion
Data
Demographics
Disease
Health
Medical Testing
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.593 seconds.